Catabasis Pharma (CATB) Tops Q2 EPS by 4c
Tweet
Share
E-mailGet Alerts CATB Hot Sheet
Join SI Premium – FREE
Catabasis Pharma (NASDAQ: CATB) reported Q2 EPS of ($0.61), $0.04 better than the analyst estimate of ($0.65).
For earnings history and earnings-related data on Catabasis Pharma (CATB) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tesla to launch Cybercab in Austin this month - report
- Aon names interim CFO as Edmund Reese exits the firm
- BofA sees Micron EPS topping $230 by FY30, calls peak fears overblown
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
